Comprehensive NeuroScience

Comprehensive NeuroScience (CNS) was a specialized contract research organization (CRO) and healthcare services company focused on central nervous system (CNS) disorders. The company provided clinical trial management, site services, and medical communications for pharmaceutical and biotechnology clients developing treatments for psychiatric and neurological conditions. CNS was recognized for its deep expertise in indications such as schizophrenia, Alzheimer's disease, and major depressive disorder. The company operated a network of clinical research sites and offered proprietary data management tools to improve the quality of CNS clinical trials. In 2009, the company was acquired by Care Management Technologies (CMT), which integrated CNS's data analytics and clinical expertise into its behavioral health management platforms.